Clinical Trials · NCT01516476
Study of RO6807952 in Patients With Diabetes Mellitus Type 2
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Hoffmann-La Roche
- Enrollment
- 2
- Start date
- Nov 2011
- Locations
- 1 site, United States
- Primary endpoint
- Change in hemoglobin A1c (HA1c)